1919 Investment Counsel’s Teva Pharmaceuticals TEVA Stock Holding History

1919 Investment Counsel’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$5.28M	Sell	98,255 -2,592	-3%	-$137K	0.11%	175
2014 Q2	$5.29M	Sell	100,847 -463	-0.5%	-$23.7K	0.11%	174
2014 Q1	$5.35M	Sell	101,310 -17,995	-15%	-$832K	0.11%	171
2013 Q4	$4.78M	Sell	119,305 -1,353	-1%	-$53.3K	0.1%	187
2013 Q3	$4.56M	Sell	120,658 -785	-0.6%	-$30.6K	0.1%	187
2013 Q2	$4.76M	Buy	+121,443	New	+$4.73M	0.11%	167

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

1919 Investment Counsel's TEVA Position: Q3 2014 in Review

1919 Investment Counsel reduced its Teva Pharmaceuticals (TEVA) stake by 2.6% in Q3 2014, selling an estimated $137K and leaving 98,255 shares worth $5.28M. The position accounts for 0.11% of the portfolio, ranked #175.

1919 Investment Counsel first reported a position in TEVA in Q2 2013 and has held it in 6 quarters since. The position peaked at $5.35M in Q1 2014. 773 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

1919 Investment Counsel held 98,255 shares of Teva Pharmaceuticals worth $5.28M as of Q3 2014.
1919 Investment Counsel sold 2,592 Teva Pharmaceuticals shares in Q3 2014, an estimated $137K.
Teva Pharmaceuticals made up 0.11% of 1919 Investment Counsel's portfolio in Q3 2014, its #175 holding.
1919 Investment Counsel first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
1919 Investment Counsel's Teva Pharmaceuticals position peaked at $5.35M in Q1 2014.
773 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.